Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06369363
EARLY_PHASE1

Estrogen Deficiency on Cardiovascular Risk

Sponsor: Milton S. Hershey Medical Center

View on ClinicalTrials.gov

Summary

To explore how estrogen deficiency impacts the blood pressure (BP) and sympathetic nerve activity (SNA), and how it impacts the production of the key pro-inflammatory mediators such as Tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). It is hypothesized that estrogen deficiency increases BP, SNA and the pathway activities of the key pro-inflammatory mediators. Those effects are impacted through the downregulation of the estrogen receptor.

Official title: Estrogen Deficiency on Cardiovascular Risk: Sympathetic Responses and Pro-inflammatory Cytokines

Key Details

Gender

FEMALE

Age Range

54 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-09

Completion Date

2028-11

Last Updated

2025-11-17

Healthy Volunteers

Yes

Interventions

DRUG

Placebo

Subjects will be assigned to 1 week of transdermal placebo patch.

DRUG

Estradiol

Subjects will be assigned to 1 week of transdermal estradiol (0.05 mg/day) patch.